Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990;30(Suppl 1):89S–98S. doi: 10.1111/j.1365-2125.1990.tb05474.x

Adenosine bronchoconstriction in asthma

Investigations into its possible mechanism of action

W H Ng, R Polosa, M K Church
PMCID: PMC1368104  PMID: 2268511

Abstract

1 Inhaled adenosine and its parent nucleotide, adenosine 5′-monophosphate (AMP) provoke bronchoconstriction in atopic and asthmatic individuals but not in normal subjects.

2 In clinical studies, histamine H1-receptor antagonists, cyclo-oxygenase inhibitors and the mast cell `stabilising' drugs, sodium cromoglycate and nedocromil, protect against the effects of adenosine bronchoprovocation suggesting the involvement of secondary mast cell mediator release.

3 Adenosine and its analogues potentiate histamine and leukotriene release from mast cells activated by other stimuli in vitro, and may also increase net mediator release from mast cells by counteracting the inhibitory effect of circulating adrenaline.

4 Although adenosine fulfils many of the criteria required for a mediator in asthma, its importance is not fully understood, and the mechanisms by which it provokes bronchoconstriction in asthmatic subjects is far from concluded.

5 Two possibilities are that either adenosine acts directly on luminal mast cells to upregulate histamine secretion, or it acts to initiate neuronal reflexes which stimulate histamine release indirectly and possibly activate peptidergic and/or cholinergic pathways.

Keywords: asthma, adenosine

Full text

PDF
89S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe M., Katsuragi T., Furukawa T. Discrimination by dipyridamole of two types of responses to adenosine and ATP of the carbachol-induced contraction of guinea-pig trachea. Eur J Pharmacol. 1983 May 20;90(1):29–34. doi: 10.1016/0014-2999(83)90210-8. [DOI] [PubMed] [Google Scholar]
  2. Bai T. R., Lam R., Prasad F. Y. Effects of adrenergic agonists and adenosine on cholinergic neurotransmission in human tracheal smooth muscle. Pulm Pharmacol. 1989;1(4):193–199. doi: 10.1016/s0952-0600(89)80017-1. [DOI] [PubMed] [Google Scholar]
  3. Barnes P., FitzGerald G., Brown M., Dollery C. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med. 1980 Jul 31;303(5):263–267. doi: 10.1056/NEJM198007313030506. [DOI] [PubMed] [Google Scholar]
  4. Braun S., Levitzki A. The attenuation of epinephrine-dependent adenylate cyclase by adenosine and the characteristics of the adenosine stimulatory and inhibitory sites. Mol Pharmacol. 1979 Nov;16(3):737–748. [PubMed] [Google Scholar]
  5. Caparrotta L., Cillo F., Fassina G., Gaion R. M. Dual effect of (-)-N6-phenylisopropyl adenosine on guinea-pig trachea. Br J Pharmacol. 1984 Sep;83(1):23–29. doi: 10.1111/j.1476-5381.1984.tb10115.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chin J. H., Delorenzo R. J. Cobalt ion enhancement of 2-chloro[3H]adenosine binding to a novel class of adenosine receptors in brain: antagonism by calcium. Brain Res. 1985 Dec 2;348(2):381–386. doi: 10.1016/0006-8993(85)90462-7. [DOI] [PubMed] [Google Scholar]
  7. Church M. K., Featherstone R. L., Cushley M. J., Mann J. S., Holgate S. T. Relationships between adenosine, cyclic nucleotides, and xanthines in asthma. J Allergy Clin Immunol. 1986 Oct;78(4 Pt 2):670–675. doi: 10.1016/0091-6749(86)90044-8. [DOI] [PubMed] [Google Scholar]
  8. Church M. K., Holgate S. T., Hughes P. J. Adenosine inhibits and potentiates IgE-dependent histamine release from human basophils by an A2-receptor mediated mechanism. Br J Pharmacol. 1983 Dec;80(4):719–726. doi: 10.1111/j.1476-5381.1983.tb10063.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Church M. K., Hughes P. J., Vardey C. J. Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cells. Br J Pharmacol. 1986 Jan;87(1):233–242. doi: 10.1111/j.1476-5381.1986.tb10176.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Clarke H., Cushley M. J., Persson C. G., Holgate S. T. The protective effects of intravenous theophylline and enprofylline against histamine- and adenosine 5'-monophosphate-provoked bronchoconstriction: implications for the mechanisms of action of xanthine derivatives in asthma. Pulm Pharmacol. 1989;2(3):147–154. doi: 10.1016/0952-0600(89)90039-2. [DOI] [PubMed] [Google Scholar]
  11. Cushley M. J., Holgate S. T. Adenosine-induced bronchoconstriction in asthma: role of mast cell-mediator release. J Allergy Clin Immunol. 1985 Feb;75(2):272–278. doi: 10.1016/0091-6749(85)90057-0. [DOI] [PubMed] [Google Scholar]
  12. Cushley M. J., Tattersfield A. E., Holgate S. T. Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. Am Rev Respir Dis. 1984 Mar;129(3):380–384. doi: 10.1164/arrd.1984.129.3.380. [DOI] [PubMed] [Google Scholar]
  13. Cushley M. J., Tattersfield A. E., Holgate S. T. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol. 1983 Feb;15(2):161–165. doi: 10.1111/j.1365-2125.1983.tb01481.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Daly J. W. Adenosine receptors: targets for future drugs. J Med Chem. 1982 Mar;25(3):197–207. doi: 10.1021/jm00345a001. [DOI] [PubMed] [Google Scholar]
  15. Daxun Z., Rafferty P., Richards R., Summerell S., Holgate S. T. Airway refractoriness to adenosine 5'-monophosphate after repeated inhalation. J Allergy Clin Immunol. 1989 Jan;83(1):152–158. doi: 10.1016/0091-6749(89)90490-9. [DOI] [PubMed] [Google Scholar]
  16. Eagle K. A., Boucher C. A. Intravenous dipyridamole infusion causes severe bronchospasm in asthmatic patients. Chest. 1989 Feb;95(2):258–259. doi: 10.1378/chest.95.2.258. [DOI] [PubMed] [Google Scholar]
  17. Fredholm B. B. Release of adenosine from rat lung by antigen and compound 48/80. Acta Physiol Scand. 1981 Apr;111(4):507–508. doi: 10.1111/j.1748-1716.1981.tb06772.x. [DOI] [PubMed] [Google Scholar]
  18. Fuller R. W., Dixon C. M., Barnes P. J. Bronchoconstrictor response to inhaled capsaicin in humans. J Appl Physiol (1985) 1985 Apr;58(4):1080–1084. doi: 10.1152/jappl.1985.58.4.1080. [DOI] [PubMed] [Google Scholar]
  19. Ginsborg B. L., Hirst G. D. The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat. J Physiol. 1972 Aug;224(3):629–645. doi: 10.1113/jphysiol.1972.sp009916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Grundström N., Andersson R. G., Wikberg J. E. Investigations on possible presynaptic effect of adenosine and noradrenaline on cholinergic neurotransmission in guinea pig trachea. Acta Pharmacol Toxicol (Copenh) 1981 Aug;49(2):158–160. doi: 10.1111/j.1600-0773.1981.tb00885.x. [DOI] [PubMed] [Google Scholar]
  21. Gustafsson L. E., Wiklund N. P., Cederqvist B. Apparent enhancement of cholinergic transmission in rabbit bronchi via adenosine A2 receptors. Eur J Pharmacol. 1986 Jan 21;120(2):179–185. doi: 10.1016/0014-2999(86)90538-8. [DOI] [PubMed] [Google Scholar]
  22. Holgate S. T., Lewis R. A., Austen K. F. Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6800–6804. doi: 10.1073/pnas.77.11.6800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hughes P. J., Church M. K. Separate purinoceptors mediate enhancement by adenosine of concanavalin A-induced mediator release and the cyclic AMP response in rat mast cells. Agents Actions. 1986 Apr;18(1-2):81–84. doi: 10.1007/BF01987989. [DOI] [PubMed] [Google Scholar]
  24. Hughes P. J., Holgate S. T., Church M. K. Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem Pharmacol. 1984 Dec 1;33(23):3847–3852. doi: 10.1016/0006-2952(84)90050-9. [DOI] [PubMed] [Google Scholar]
  25. Kurtz A. Adenosine stimulates guanylate cyclase activity in vascular smooth muscle cells. J Biol Chem. 1987 May 5;262(13):6296–6300. [PubMed] [Google Scholar]
  26. Maclagan J. Factors which modify neural control of the airway. Prog Clin Biol Res. 1988;263:149–157. [PubMed] [Google Scholar]
  27. Mann J. S., Cushley M. J., Holgate S. T. Adenosine-induced bronchoconstriction in asthma. Role of parasympathetic stimulation and adrenergic inhibition. Am Rev Respir Dis. 1985 Jul;132(1):1–6. doi: 10.1164/arrd.1985.132.1.1. [DOI] [PubMed] [Google Scholar]
  28. Mann J. S., Holgate S. T., Renwick A. G., Cushley M. J. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol (1985) 1986 Nov;61(5):1667–1676. doi: 10.1152/jappl.1986.61.5.1667. [DOI] [PubMed] [Google Scholar]
  29. Mann J. S., Holgate S. T. Specific antagonism of adenosine-induced bronchoconstriction in asthma by oral theophylline. Br J Clin Pharmacol. 1985 May;19(5):685–692. doi: 10.1111/j.1365-2125.1985.tb02696.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mann J. S., Renwick A. G., Holgate S. T. Release of adenosine and its metabolites from activated human leucocytes. Clin Sci (Lond) 1986 May;70(5):461–468. doi: 10.1042/cs0700461. [DOI] [PubMed] [Google Scholar]
  31. Marquardt D. L., Parker C. W., Sullivan T. J. Potentiation of mast cell mediator release by adenosine. J Immunol. 1978 Mar;120(3):871–878. [PubMed] [Google Scholar]
  32. Marquardt D. L., Walker L. L., Wasserman S. I. Adenosine receptors on mouse bone marrow-derived mast cells: functional significance and regulation by aminophylline. J Immunol. 1984 Aug;133(2):932–937. [PubMed] [Google Scholar]
  33. Mentzer R. M., Jr, Rubio R., Berne R. M. Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol. 1975 Dec;229(6):1625–1631. doi: 10.1152/ajplegacy.1975.229.6.1625. [DOI] [PubMed] [Google Scholar]
  34. Nishibori M., Shimamura K., Yokoyama H., Tsutsumi K., Saeki K. Differential effects of adenosine on histamine secretion induced by antigen and chemical stimuli. Arch Int Pharmacodyn Ther. 1983 Sep;265(1):17–28. [PubMed] [Google Scholar]
  35. Ollerenshaw S., Jarvis D., Woolcock A., Sullivan C., Scheibner T. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med. 1989 May 11;320(19):1244–1248. doi: 10.1056/NEJM198905113201904. [DOI] [PubMed] [Google Scholar]
  36. Pauwels R. A., Van der Straeten M. E. An animal model for adenosine-induced bronchoconstriction. Am Rev Respir Dis. 1987 Aug;136(2):374–378. doi: 10.1164/ajrccm/136.2.374. [DOI] [PubMed] [Google Scholar]
  37. Peachell P. T., Columbo M., Kagey-Sobotka A., Lichtenstein L. M., Marone G. Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis. 1988 Nov;138(5):1143–1151. doi: 10.1164/ajrccm/138.5.1143. [DOI] [PubMed] [Google Scholar]
  38. Phillips G. D., Bagga P. K., Djukanovic R., Holgate S. T. The influence of refractoriness to adenosine 5'-monophosphate on allergen-provoked bronchoconstriction in asthma. Am Rev Respir Dis. 1989 Aug;140(2):321–326. doi: 10.1164/ajrccm/140.2.321. [DOI] [PubMed] [Google Scholar]
  39. Phillips G. D., Holgate S. T. Absence of a late-phase response or increase in histamine responsiveness after bronchial provocation with adenosine 5'-monophosphate in atopic and non-atopic asthma. Clin Sci (Lond) 1988 Oct;75(4):429–436. doi: 10.1042/cs0750429. [DOI] [PubMed] [Google Scholar]
  40. Phillips G. D., Holgate S. T. The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5'-monophosphate in nonatopic asthma. Am Rev Respir Dis. 1989 Feb;139(2):463–469. doi: 10.1164/ajrccm/139.2.463. [DOI] [PubMed] [Google Scholar]
  41. Phillips G. D., Ng W. H., Church M. K., Holgate S. T. The response of plasma histamine to bronchoprovocation with methacholine, adenosine 5'-monophosphate, and allergen in atopic nonasthmatic subjects. Am Rev Respir Dis. 1990 Jan;141(1):9–13. doi: 10.1164/ajrccm/141.1.9. [DOI] [PubMed] [Google Scholar]
  42. Rafferty P., Beasley R., Holgate S. T. The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma. Am Rev Respir Dis. 1987 Aug;136(2):369–373. doi: 10.1164/ajrccm/136.2.369. [DOI] [PubMed] [Google Scholar]
  43. Rubio R., Bencherif M. Adenosine: sites of release in the nervous system and control of phosphatidylinositol turnover. Prog Clin Biol Res. 1987;230:77–93. [PubMed] [Google Scholar]
  44. Satchell D., Smith R. Adenosine causes contractions in spiral strips and relaxations in transverse strips of guinea-pig trachea: studies on mechanism of action. Eur J Pharmacol. 1984 Jun 1;101(3-4):243–247. doi: 10.1016/0014-2999(84)90163-8. [DOI] [PubMed] [Google Scholar]
  45. Snyder S. H. Adenosine as a neuromodulator. Annu Rev Neurosci. 1985;8:103–124. doi: 10.1146/annurev.ne.08.030185.000535. [DOI] [PubMed] [Google Scholar]
  46. Welton A. F., Simko B. A. Regulatory role of adenosine in antigen-induced histamine release from the lung tissue of actively sensitized guinea pigs. Biochem Pharmacol. 1980 Apr 15;29(8):1085–1092. doi: 10.1016/0006-2952(80)90400-1. [DOI] [PubMed] [Google Scholar]
  47. Zgombick J. M., Beck S. G., Mahle C. D., Craddock-Royal B., Maayani S. Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies. Mol Pharmacol. 1989 Apr;35(4):484–494. [PubMed] [Google Scholar]
  48. van Calker D., Müller M., Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 1979 Nov;33(5):999–1005. doi: 10.1111/j.1471-4159.1979.tb05236.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES